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ABSTRACT
Objective: The aim of this study was to develop and validate analytical methods for determining methamphetamine in saliva using gas chromatography-
tandem mass spectrometry (MS).
Methods: The chromatography conditions were DB MS-5 capillary columns with a length of 30 m, inner diameter of 0.25 mm, mobile phase of Helium 
gas 99.999%, flow rate of 0.8 mL/min, detection of MS at m/z values of 58.00 and 91.00, respectively, and ephedrine HCl as the internal standard.
Results: The validation of analytical methods for methamphetamine satisfies the validation criteria by the EMEA Guidelines 2011. Bioanalytical 
methods obtained were linear in the concentration range from 15.0 to 300.0 ng/mL with r>0.9999. Sample preparation was done using liquid–liquid 
microextraction with cyclohexane, supernatant residue was dried and reconstituted with approximately 100 µL of methanol.
Conclusion: The method was successfully applied to saliva samples of methamphetamine users with levels in the range of test.
Keywords: Methamphetamine, Optimum, Validation, Human saliva, Ephedrine HCl.
INTRODUCTION
Methamphetamine, known as shabu in Indonesia, is a very strong 
central nervous system stimulant from the amphetamine group [1,2]. 
To determine the evidence of methamphetamine abuse, a test to 
detect methamphetamine in the body is required. Methamphetamine 
levels in the body are usually detected using the blood and urine [1-4]. 
However, saliva is simpler to obtain and more efficient sample for 
methamphetamine tests in the body [4].
Narcotics are substances or drugs, derived from herbs or synthetic, that 
can cause altered levels of consciousness, loss of sensation, reduction 
in pain, and addiction [1]. Narcotics are also needed to treat certain 
diseases but, if misused, can be disadvantageous to the person and, 
moreover, to the community. In the year 2013, the amount of confiscated 
shabu rapidly increased compared with that in the year 2012 [5]. This 
shows that methamphetamine is a drug which is used a lot in society.
In Indonesia, drug abuse is a criminal act and needs to be judged by the 
law; thus, its intake needs to be proven. Until now, urine, blood, hair, and 
other body part tests have been performed to determine the presence 
of the drug in the body. The oral liquid or saliva test is a fast and non-
invasive alternative to these tests. The main analyte is suspected to not 
undergo metabolism in the saliva. In addition, while collecting blood 
samples requires professional skills, collecting saliva does not [6].
Unlike urine samples, saliva can be collected under supervision without 
disturbing privacy. Most drugs are bound strongly to blood protein, based 
on the consideration that only free fractions of a drug are pharmacologically 
active. Saliva contains only a small part of the free fraction of drug. This 
can be filtrated from the salivary tissue, including the capillary wall, basal 
membrane, and epithelial cells of salivary glands [6].
Methods to analyze methamphetamine in saliva samples using 
gas chromatography-tandem mass spectrometry (GC-MS) are still 
limited. According to other studies, the maximum concentration 
of methamphetamine in saliva can reach 300 ng/mL 4 h after drug 
usage, whereas the maximum concentration in blood plasma can reach 
35 ng/mL 4 h after usage [7]. Meanwhile, maximum concentration of 
methamphetamine in urine can reach 4500 ng/mL 16 h after usage [8]. 
Therefore, an analysis method that is sensitive and selective is needed if 
saliva is to be used as a biological test sample.
According to a previous research, methamphetamine can be extracted 
from saliva using a liquid–liquid extraction method. Along with the 
development of an analysis instrument, the modern analytical chemistry 
trend has shifted to simplification and minimalization of sample 
preparation. Currently, many innovative microextraction techniques 
have been developed which can simplify the sample preparation 
procedure and increase quality and sensitivity of the analysis. In the 
previous studies, liquid–liquid extraction was combined with GC, 
capillary electrophoresis, and high-performance liquid chromatography 
[9-11]. This technique was suitable for forensic examination of drug 
abuse using minimal sample volume and short analysis time.
In this study, the aim of this was to determine the concentration of 
methamphetamine in saliva samples using GC-MS with microextraction 
methods, using cyclohexane as a solvent extractor and ephedrine HCl 
as an internal standard. This method can hopefully be applied in the 
forensic laboratory to test for methamphetamine abuse.
MATERIALS AND METHODS
Equipment
GC-MS (Shimadzu GCMS-QP2010 Ultra), equipped with DB-5 MS 
Capillary Column (0.25 mm x 30 m; 0.25µm), data processing software 
(Windows Software) and a computer (HP).Other equipments were 
microcentrifuge (Spectrafuge 16M), analytical balance (Sartorius), 
ultrasonic mixer (Mmert, vortex, and micropipette (Eppendorf)
Materials
Materials used in the research were as follows: Methamphetamine 
standard (Cerrilant); internal standard ephedrine HCl (NADFC); 
methanol, cyclohexane, chloroform, and NaOH were purchased from 
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Merck; Aquabidest (Ikapharmindo); control saliva sample, and saliva 
sample from a drug user (Indonesian National Narcotics Agency).
Standard solution, internal standard, and quality control (QC) 
solution
Methamphetamine standard (0.1 mL) was pipetted into a 10.0 mL 
volumetric flask. The substance was dissolved in 2 mL of methanol; 
then, methanol was added to the limit of the flask. The concentration 
of standard solution was 0.01 mg/mL. Ephedrine was used as internal 
standard and was weighed 5.0 mg and then added to a 5.0 mL 
volumetric flask. The substance was dissolved in methanol (2 mL), 
and then, methanol was added to the limit of the volumetric flask. The 
internal standard solution obtained had a concentration of 1.0 mg/mL. 
The internal standard solution and standard solution were then stored 
at 4°C.
Instrumentation and chromatography conditions
GC was performed at a column temperature of 280°C and flow rate of 
0.8 mL/min. The mobile phase used was helium 99.999%. Injection 
volume was 1 µL.
The ionization parameters were as follows: Capillary pipe voltage, 
3.5 kV; ion source temperature, 230°C, interface temperature, 250°C; 
and solvent cut time, 1.5 min. The m/z value obtained was the ratio of 
the main ion molecular weight and product ion molecular weight. The 
m/z values used in the methamphetamine and ephedrine HCl analyses 
were 58.00 and 91.00, respectively.
After determining optimum conditions for methamphetamine analysis, 
mixed solutions of methamphetamine and internal standard were 
injected 6 times and coefficients of variation (CV) for retention times 
and areas under the curve for each substance were then calculated 
as peak area ratio (PAR), which a CV should be <2.0%. From this 
experiment, PAR was obtained with a CV of <2.0% (Table 1).
Sample preparation
Sample preparation was performed with saliva containing 
methamphetamine. The solvent containing 300 µL cyclohexane and 
100 ng/mL internal standard ephedrine HCl was added into the tube. 
The tube was sonicated at 55°C for
7 min. The tube was then centrifuged for 5 min at 3000 rpm. The 
supernatant was pipetted to other tube to be evaporated. The residue 
was reconstituted with 100 µL methanol and mixed by vortex for 10 s. 
The solvent was subsequently inserted into the autosampler vial, and 
1 µL of the sample was injected into the GC-MS system (Fig. 1).
Bioanalysis method validation
The lower limit of quantification (LLOQ) was determined by dissolving 
the lowest concentration from the methamphetamine calibration curve 
(15 ng/mL) until it was halved and then quartered. The concentration 
of the solution was then calculated by injecting it into the GC-MS. This 
assay was replicated 5 times. From the calculated concentration, the 
percentage difference (% diff) system and CV were obtained with a 
requirement of <±20%.
A calibration curve of standard solution was prepared by dissolving 
the standard solution (methamphetamine, 1000 ng/mL) until a 
concentration of 15–300 ng/mL was obtained. The methamphetamine 
solution was then dissolved with saliva to obtain a concentration 
range of 20–300 ng/mL. The correlation coefficient (r) of the linear 
regression line equation was calculated to obtain a linearity curve. The 
result showed that %diff obtained A was not exceeding ±15% for all 
concentrations, except LLOQ. LLOQ value obtained was not exceeding 
±20%.
Selectivity of the method was determined by preparing saliva which 
contained the standard methamphetamine solution at the LLOQ 
concentration, and then, sample preparation was performed at 
15 ng/mL. The value of %diff and % CV was not to exceed ±20%. The 
test was conducted using saliva from six different sources, and for each 
of these, a blank measurement was done with the LLOQ concentration 
and replicated twice.
Accuracy and precision were determined by preparing a standard 
solution of methamphetamine at the concentration of LLOQ, QCL, 
QCM, and QCH. Sample preparation was performed using saliva, 
and 1 μL of the solution injected to the GC-MS system. Accuracy was 
calculated from the %diff value to see the relationship between the 
concentrations obtained from measurement compare to the actual 
concentration. The test was conducted within-run and between-run. 
Accuracy was calculated using at least four concentrations of standard 
solution, with each of them replicated 5 times. The within-run test was 
conducted 3 times on at least two different days. Value %diff and % 
CV were not to exceed ±15% for all concentrations, except LLOQ (not 
exceeding ±20%). Value of recovery was calculated by comparing the 
area of the extraction result to the area of standard solution of the same 
concentration.
Carryover was performed by preparing the blank saliva solution and 
samples which contained methamphetamine at upper LOQ (ULOQ). 
Aliquot from the extraction process of blank saliva (1 μL) was injected 
into the GC-MS system after injecting the standard solution which 
contained methamphetamine at the concentration of the ULOQ. Peak 
area of methamphetamine and the internal standard that appeared in 
the blank was observed. This test was replicated 5 times.
The integrity of dilution was determined by preparing a sample saliva 
which contained methamphetamine at the concentration of 225 ng/mL. 
The solution was dissolved with blank saliva until halved and also a 
quarter of the concentration was acquired. The dilution solution was then 
prepared, and 1 μL of the final solution was injected into the GC-MS 
system. The test was replicated 5 times to acquire accuracy and precision.
The matrix effect was determined by preparing a blank saliva for 
sample preparation. The acquired supernatant was then added with 
methamphetamine of low concentration (QCL) and high concentration 
(QCH) and, thus, added the internal standard (100 μg/mL). The final 
solution (1 μL) was then injected into the GC-MS system. After that, the 
standard methamphetamine solution was prepared at low concentration 
(QCL) and high concentration (QCH) and the internal standard at 
Table 1: System suitability test results*
Data No. Retention time (min) Area (µV.s)
Methamphetamine IS Methamphetamine IS PAR
1 5.428 6.946 1025946 218530 4.6947
2 5.434 6.946 1019306 222837 4.5742
3 5.426 6.946 1022766 222863 4.5892
4 5.427 6.946 1035906 225997 4.5837
5 5.426 6.944 1027644 225618 4.5547
6 5.428 6.945 1026313.6 223169 4.5993
Mean±SD 5.428±0.00 6.945±0.00 1026313.6±6237.21 223169±2988.28 4.5993±0.0549
CV (%) 0.06 0.01 0.61 1.34 1.1941
PAR: Peak area ratio, CV: Coefficients of variation, SD: Standard deviation
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100 μg/mL. The solution (1 μL) was then injected into the GC-MS. The 
matrix effect was obtained by calculating the matrix factor, which was 
to compare the peak area of methamphetamine and internal standard 
within the saliva and the peak area of methamphetamine and internal 
standard within the standard solution. The matrix factor was normalized 
by the internal standard and then counted by dividing the matric factor 
of analyte with the matrix factor of internal standard. The matrix effect 
was fulfilled the criteria because % CV value for each concentration not 
exceeding 15%.
The stability test included stock solution stability, long-term stability 
(30 days), and short-term stability (0, 6, and 24 h) and autosampler 
stability (0 and 24 h). For the stock solution stability test, a QC sample 
of methamphetamine at low and high concentrations was prepared 
and stored at −20°C. For the short-term stability test, saliva was kept at 
room temperature. Autosampler stability was performed by reserving 
the sample, which was injected at 0 and 24 h.
RESULTS AND DISCUSSION
Determining the LLOQ
The value of LLOQ was determined by preparing a calibration curve of a 
standard solution with concentrations of 15–300 ng/mL. The 15 ng/mL 
concentration of standard solution was considered as the temporary 
LLOQ, and then, this was repeated 5 times. The value of %diff and CV 
at the concentration of 15 ng/mL fulfilled the accuracy and precision 
criteria, which was <±20%. Subsequently, the solution was diluted to 
half (7.5 ng/mL) and five replicas were made, but the results did not 
fulfil the criteria.
Linearity/calibration curve
For analyzing methamphetamine in saliva, a calibration curve was prepared 
with a range of 15–300 ng/mL. The calibration curve was prepared using blank 
saliva (saliva without the analyte and internal standard), zero sample (saliva with 
the internal standard), and non-zero saliva (saliva with the analyte and internal 
standard) at seven concentrations: 15, 30, 50, 75, 100, 200, and 300 ng/mL.
Calibration curve analysis was conducted by looking at the linearity 
parameter (r>0.9990) and accuracy (%diff not exceeding ±15%, 
except for LLOQ concentration [not exceeding ±20%]). One of 
the measurements of the calibration curve is shown in Fig. 2. The 
calibration curve produced the following linear regression equation: 
y=0.0004+0.0005x with r=0.9999; where x is the methamphetamine 
concentration (ng/mL) and y is PAR between methamphetamine and 
internal standard ephedrine HCl.
A calibration curve was prepared for every analysis to minimalize the 
possibility of measurement error because of the changing conditions 
of the GC-MS system on different days. Therefore, the calibration curve 
had to fulfil the precision criteria every time a calibration curve was 
made, by looking at the CV value of each of the concentrations of the 
calibration curves (not exceeding ±15%; except LLOQ, which was not 
exceeding ±20%). According to data, the CV value that was obtained did 
not exceed ±15% for all concentrations, including LLOQ, with a mean r 
of 0.9990 (Fig. 2).
Accuracy, precision, and recovery test
At the within-run measurement of accuracy, the %diff value obtained 
for LLOQ concentration was within the range of −2.07%–+7.65% and 
for QC concentration was within the range of −6.10%–+6.97%. The 
within-run measurement of precision obtained a CV value of <5.14% 
for LLOQ and QC concentration. For the within-run measurement, the 
accuracy obtained for LLOQ concentration was a %diff value ranging 
from −19.81% to +18.87% and for QC concentration was from −4.43% 
to +8.77%. The between-run for precision the CV value was <15.5%. 
The values of %diff and CV for the within-run and between-run tests 
fulfilled the requirements for accuracy and precision.
Carryover
The result achieved from peak area percentage from blank saliva at 
methamphetamine retention time <8.33% with mean of 5.90%, so it 
fulfilled the requirement of <20%. The peak area percentage for blank 
saliva and ephedrine HCl retention time was <0.51% with a mean of 
0.40%.
Dilution integrity
The methamphetamine solution in the saliva was made with QCH 
concentration (225.0 ng/mL). Then, dilution was done to halve the 
concentration to 112.50 ng/mL and halved again to 56.25 ng/mL. The 
Fig. 1: Working scheme of salivary sample preparation
Fig. 2: Methamphetamine calibration curve
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integrity test for methamphetamine dilution fulfilled the requirements 
of value %diff at the half QCH concentration (−6.48–− to tion w at the 
quarter of QCH (–8.30–− to tion w at the quarter was obtained was 
2.11% for half ULOQ and 1.29% for quarter ULOQ. With this method, 
it can be concluded that dilution will not influence the accuracy and 
precision.
Selectivity
The selectivity test was performed using the analyte with LLOQ 
concentration (15 ng/mL) and blank saliva from six different sources. 
This was done to look at the ability of the analysis method in the 
quantitative measurement of LLOQ concentration and to observe any 
interference of blank saliva using different saliva. In this research, the 
value % analyte interference was obtained at 8.42–11.61% and fulfilled 
the requirement of <±20%, with a CV for LLOQ of 11.13%. Other than 
that, the percentage interferences of internal standard ephedrine HCl 
was obtained at 0%.
Matrix effect
The matrix effect of methamphetamine was 80.79% at QCL and 73.73% 
at QCH. That result showed that ionization suppression happened to the 
analyte which was possibly caused by the existence of many matrices 
other than the analyte that can disturb the ionization process during 
MS. The CV value from the analyte fulfilled the requirements of EMEA 
(CV value achieved from six different saliva sources not exceeding 15%).
Stability test
The short-term stability test of the stock solution was conducted for 
24 h at room temperature, and the long-term stability test for 30 days 
at 4°C. The results obtained were: %Diff value for the stability of 
methamphetamine stock solution in short term: −0.14% to 0.16%; 
and %diff value for stability for ephedrine HCl stock solution in short 
term: −1.09–1.08%. This result shows that the stock solution of 
methamphetamine and ephedrine HCl was stable when kept at room 
temperature for at least 24 h. For long-term stability, value %diff 
for stock solution of methamphetamine was −0.08–+0.07% and for 
ephedrine HCl was −1.92–− to % and fo days storage at temperature of 
4°C. Based on these results, the stock solution for methamphetamine 
and ephedrine HCl can be stored for at least 30 days.
The short-term stability test was performed by storing QCH and QCL at 
room temperature for 24 h and then observed for its stability at 0, 6, and 
24 h. The %diff value after 24 h for QCL concentration starts from 7.21% 
up to 9.19% and for QCH start from 4.47% up to 9.03%. This showed that 
methamphetamine in saliva can be kept at room temperature for at least 
24 h. The long-term stability test was done by keeping QCL and QCH at 
−4°C for 30 days and then analyzed at day 0 and day 30. According to 
the result, the value %diff at day 30 of QCL concentration was between 
−5.20% and −nd day This showed that methamphetamine in saliva was 
stable and can be stored at a temperature of −4°C for at least 30 days.
CONCLUSION
The developed method for determination methamphetamine in saliva 
was simple and easy with liquid-liquid microextraction. The method was 
valid and linear at the concentration range of 15.0–300.0 ng/mL with 
r >0.9999 and can be applied to saliva samples of methamphetamine 
users. Furthermore, the stock solution of methamphetamine and 
ephedrine HCl was stable when kept at room temperature for at least 
24 h and can be stored for at least 30 days.
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